Rubén Fernández‐Santiago

Biomedical Research Networking Center on Neurodegenerative Diseases — Spain

Medicine · Health Sciences

34h-index5.9kcitations93works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(59), RNA regulation and disease(19), Neurological diseases and metabolism(16), Amyotrophic Lateral Sclerosis Research(13), Lysosomal Storage Disorders Research(12)

Publications87 total

Author response: Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity
2025Open Access
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity
2025Open Access
Phospho-signalling deregulation of the mTOR pathway in fibroblasts from LRRK2 Parkinson’s patients
2025Open Access
Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson’s disease
2025Open Access
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity
2025Open Access
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity
2025· 1 citedOpen Access
Phospho-Ser235-Rps6 and Il-6 Define a Peripheral Inflammatory Signature in Idiopathic and Lrrk2 G2019s-Associated Parkinson’S Disease: A Functional Validation
SSRN Electronic Journal·2025Open Access
α‐Synuclein Gene Hypomethylation in <scp>LRRK2</scp> Parkinson's Disease Patients
Movement Disorders·2024· 7 citedOpen Access
In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s disease
Brain·2024· 5 citedOpen Access
<scp>DRD4</scp> gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease
Annals of Clinical and Translational Neurology·2024· 3 citedOpen Access
In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s
2024Open Access
Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
Neurology Genetics·2023· 2 citedOpen Access
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity
2023Open Access
DRD4 Gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease.
Research Square (Research Square)·2023Open Access
Cumulative Genetic Score and <i>C9orf72</i> Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
Neurology Genetics·2023· 14 citedOpen Access
Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
npj Parkinson s Disease·2023· 12 citedOpen Access
Cumulative genetic risk and <i>C9orf72</i> repeat status independently associate with ALS status in two case-control studies
2022Open Access
Serum <scp>MicroRNAs</scp> Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
Movement Disorders·2022· 21 citedOpen Access
Increased <scp>Phospho‐AKT</scp> in Blood Cells from <scp><i>LRRK2</i> G2019S</scp> Mutation Carriers
Annals of Neurology·2022· 2 citedOpen Access
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Ageing Research Reviews·2022· 25 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Mario Ezquerra(37), Manel Fernández(18), Yaroslau Compta(16), Eduardo Tolosa(14), Eduard Tolosa(12), Francesc Valldeoriola(11), Marı́a José Martı́(11), Thomas Gasser(10), Claustre Pont‐Sunyer(10), Sara Bandrés‐Ciga(9), Cornelis Blauwendraat(7), Andrew Singleton(7), Carles Gaig(7), María‐José Martí(7), Esteban Muñoz(7), Mike A. Nalls(6), Juan A. Botía(6), Alexis Brice(6), Ziv Gan‐Or(6), Huw R. Morris(6)